D. Ross Ramidge, University of Colorado Denver (IMAGE)

University of Colorado Anschutz Medical Campus

D. Ross Ramidge, University of Colorado Denver

Caption

D. Ross Camidge, M.D., Ph.D., investigator at the University of Colorado Cancer Center and colleagues report promising results of rociletinib against EGFR-positive lung cancer.

Credit

CU Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.